Neurosurgeon Testifies at FDA Hearing on Medical Device User Fees

On Sept. 30, Peter E. Konrad, MD, PhD, FAANS, represented the AANS/CNS Drugs and Devices Committee at a Medical Device User Fee Amendments (MDUFA) stakeholders meeting. The meeting focused on discussions on diversity and equity for neurosurgical devices, including access to neurostimulators and pediatric devices. Negotiations to reauthorize MDUFA for fiscal years 2023 through 2027 are underway in Congress, as the current legislative authority for the program expires on September 30, 2022. Representatives from the AANS and the CNS will engage in this process as the negotiations continue.

Click here for meeting details.